Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Oral Tofacitinib in Combination With Narrow Band UVB in the Treatment of Vitiligo

NCT07044141 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.

NCT NCT07044141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07044141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Oral Tofacitinib in Combination With Narrow Band UVB in the Treatment of Vitiligo
Lead sponsor
Lahore General Hospital
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 1, 2025
Completion date
September 30, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo